199 related articles for article (PubMed ID: 32968110)
1. Hepatic lipocalin 2 promotes liver fibrosis and portal hypertension.
Chen J; Argemi J; Odena G; Xu MJ; Cai Y; Massey V; Parrish A; Vadigepalli R; Altamirano J; Cabezas J; Gines P; Caballeria J; Snider N; Sancho-Bru P; Akira S; Rusyn I; Gao B; Bataller R
Sci Rep; 2020 Sep; 10(1):15558. PubMed ID: 32968110
[TBL] [Abstract][Full Text] [Related]
2. Loss of SREBP-1c ameliorates iron-induced liver fibrosis by decreasing lipocalin-2.
Lee EH; Lee JH; Kim DY; Lee YS; Jo Y; Dao T; Kim KE; Song DK; Seo JH; Seo YK; Seong JK; Moon C; Han E; Kim MK; Ryu S; Shin M; Roh GS; Jung HR; Osborne TF; Ryu D; Jeon TI; Im SS
Exp Mol Med; 2024 Apr; 56(4):1001-1012. PubMed ID: 38622198
[TBL] [Abstract][Full Text] [Related]
3. Chronic mineral oil administration increases hepatic inflammation in wild type mice compared to lipocalin 2 null mice.
Borkham-Kamphorst E; Haas U; Pinoé-Schmidt M; Abdallah AT; Weiskirchen R
Lab Invest; 2021 Dec; 101(12):1528-1539. PubMed ID: 34518636
[TBL] [Abstract][Full Text] [Related]
4. Essential role of suppressor of cytokine signaling 1 (SOCS1) in hepatocytes and macrophages in the regulation of liver fibrosis.
Mafanda EK; Kandhi R; Bobbala D; Khan MGM; Nandi M; Menendez A; Ramanathan S; Ilangumaran S
Cytokine; 2019 Dec; 124():154501. PubMed ID: 30097285
[TBL] [Abstract][Full Text] [Related]
5. Histopathological and Molecular Signatures of a Mouse Model of Acute-on-Chronic Alcoholic Liver Injury Demonstrate Concordance With Human Alcoholic Hepatitis.
Furuya S; Cichocki JA; Konganti K; Dreval K; Uehara T; Katou Y; Fukushima H; Kono H; Pogribny IP; Argemi J; Bataller R; Rusyn I
Toxicol Sci; 2019 Aug; 170(2):427-437. PubMed ID: 30517762
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of lipocalin-2 (LCN2) in acute liver injury suggest a novel function in liver homeostasis.
Borkham-Kamphorst E; van de Leur E; Zimmermann HW; Karlmark KR; Tihaa L; Haas U; Tacke F; Berger T; Mak TW; Weiskirchen R
Biochim Biophys Acta; 2013 May; 1832(5):660-73. PubMed ID: 23376114
[TBL] [Abstract][Full Text] [Related]
7. Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor-dependent inhibition of hepatic stellate cell contraction.
Xu W; Lu C; Zhang F; Shao J; Yao S; Zheng S
FEBS J; 2017 Jan; 284(1):114-133. PubMed ID: 27896916
[TBL] [Abstract][Full Text] [Related]
8. Circulating lipocalin 2 is neither related to liver steatosis in patients with non-alcoholic fatty liver disease nor to residual liver function in cirrhosis.
Meier EM; Pohl R; Rein-Fischboeck L; Schacherer D; Eisinger K; Wiest R; Krautbauer S; Buechler C
Cytokine; 2016 Sep; 85():45-50. PubMed ID: 27288631
[TBL] [Abstract][Full Text] [Related]
9. Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1β through nuclear factor-κB activation.
Borkham-Kamphorst E; Drews F; Weiskirchen R
Liver Int; 2011 May; 31(5):656-65. PubMed ID: 21457438
[TBL] [Abstract][Full Text] [Related]
10. Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity.
Colmenero J; Bataller R; Sancho-Bru P; Bellot P; Miquel R; Moreno M; Jares P; Bosch J; Arroyo V; Caballería J; Ginès P
Gastroenterology; 2007 Feb; 132(2):687-97. PubMed ID: 17258719
[TBL] [Abstract][Full Text] [Related]
11. Spleen-derived lipocalin-2 in the portal vein regulates Kupffer cells activation and attenuates the development of liver fibrosis in mice.
Aoyama T; Kuwahara-Arai K; Uchiyama A; Kon K; Okubo H; Yamashina S; Ikejima K; Kokubu S; Miyazaki A; Watanabe S
Lab Invest; 2017 Aug; 97(8):890-902. PubMed ID: 28504685
[TBL] [Abstract][Full Text] [Related]
12. STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib.
Deng YR; Ma HD; Tsuneyama K; Yang W; Wang YH; Lu FT; Liu CH; Liu P; He XS; Diehl AM; Gershwin ME; Lian ZX
J Autoimmun; 2013 Oct; 46():25-34. PubMed ID: 23948302
[TBL] [Abstract][Full Text] [Related]
13. Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis.
Klein S; Rick J; Lehmann J; Schierwagen R; Schierwagen IG; Verbeke L; Hittatiya K; Uschner FE; Manekeller S; Strassburg CP; Wagner KU; Sayeski PP; Wolf D; Laleman W; Sauerbruch T; Trebicka J
Gut; 2017 Jan; 66(1):145-155. PubMed ID: 26385087
[TBL] [Abstract][Full Text] [Related]
14. Chronic Carbon Tetrachloride Applications Induced Hepatocyte Apoptosis in Lipocalin 2 Null Mice Through Endoplasmic Reticulum Stress and Unfolded Protein Response.
Borkham-Kamphorst E; Haas U; Van de Leur E; Trevanich A; Weiskirchen R
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718038
[TBL] [Abstract][Full Text] [Related]
15. Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis.
Dominguez M; Miquel R; Colmenero J; Moreno M; García-Pagán JC; Bosch J; Arroyo V; Ginès P; Caballería J; Bataller R
Gastroenterology; 2009 May; 136(5):1639-50. PubMed ID: 19208360
[TBL] [Abstract][Full Text] [Related]
16. Fibromodulin, an oxidative stress-sensitive proteoglycan, regulates the fibrogenic response to liver injury in mice.
Mormone E; Lu Y; Ge X; Fiel MI; Nieto N
Gastroenterology; 2012 Mar; 142(3):612-621.e5. PubMed ID: 22138190
[TBL] [Abstract][Full Text] [Related]
17. Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans.
Xu MJ; Cai Y; Wang H; Altamirano J; Chang B; Bertola A; Odena G; Lu J; Tanaka N; Matsusue K; Matsubara T; Mukhopadhyay P; Kimura S; Pacher P; Gonzalez FJ; Bataller R; Gao B
Gastroenterology; 2015 Oct; 149(4):1030-41.e6. PubMed ID: 26099526
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of apoptosis protects mice from ethanol-mediated acceleration of early markers of CCl4 -induced fibrosis but not steatosis or inflammation.
Roychowdhury S; Chiang DJ; Mandal P; McMullen MR; Liu X; Cohen JI; Pollard J; Feldstein AE; Nagy LE
Alcohol Clin Exp Res; 2012 Jul; 36(7):1139-47. PubMed ID: 22273278
[TBL] [Abstract][Full Text] [Related]
19. Carvedilol improves liver cirrhosis in rats by inhibiting hepatic stellate cell activation, proliferation, invasion and collagen synthesis.
Ling L; Li G; Wang G; Meng D; Li Z; Zhang C
Mol Med Rep; 2019 Aug; 20(2):1605-1612. PubMed ID: 31257490
[TBL] [Abstract][Full Text] [Related]
20. A new Mdr2(-/-) mouse model of sclerosing cholangitis with rapid fibrosis progression, early-onset portal hypertension, and liver cancer.
Ikenaga N; Liu SB; Sverdlov DY; Yoshida S; Nasser I; Ke Q; Kang PM; Popov Y
Am J Pathol; 2015 Feb; 185(2):325-34. PubMed ID: 25478810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
